litlas
ログインアカウント作成

Michele Baccarani

1979–2022 年に発表

182
論文数
51,251
被引用数
111
h 指数
182
i10 指数

被引用数

Michele Baccarani の年別被引用数1979 年: 被引用 29 件1980 年: 被引用 1 件1982 年: 被引用 7 件1983 年: 被引用 5 件1984 年: 被引用 6 件1985 年: 被引用 5 件1986 年: 被引用 4 件1987 年: 被引用 5 件1988 年: 被引用 5 件1989 年: 被引用 1 件1990 年: 被引用 11 件1991 年: 被引用 2 件1992 年: 被引用 4 件1993 年: 被引用 8 件1994 年: 被引用 6 件1995 年: 被引用 7 件1996 年: 被引用 7 件1997 年: 被引用 9 件1998 年: 被引用 17 件1999 年: 被引用 15 件2000 年: 被引用 22 件2001 年: 被引用 25 件2002 年: 被引用 40 件2003 年: 被引用 146 件2004 年: 被引用 148 件2005 年: 被引用 161 件2006 年: 被引用 214 件2007 年: 被引用 360 件2008 年: 被引用 357 件2009 年: 被引用 461 件2010 年: 被引用 361 件2011 年: 被引用 438 件2012 年: 被引用 452 件2013 年: 被引用 406 件2014 年: 被引用 414 件2015 年: 被引用 484 件2016 年: 被引用 433 件2017 年: 被引用 330 件2018 年: 被引用 287 件2019 年: 被引用 1,144 件2020 年: 被引用 1,222 件2021 年: 被引用 1,099 件2022 年: 被引用 737 件2023 年: 被引用 404 件2024 年: 被引用 863 件2025 年: 被引用 315 件2026 年: 被引用 4 件1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,760 件、この内訳の 24.4%イタリア: 引用元論文 1,049 件、この内訳の 9.3%ドイツ: 引用元論文 873 件、この内訳の 7.7%イギリス: 引用元論文 764 件、この内訳の 6.8%フランス: 引用元論文 692 件、この内訳の 6.1%中国: 引用元論文 580 件、この内訳の 5.1%スペイン: 引用元論文 373 件、この内訳の 3.3%オランダ: 引用元論文 337 件、この内訳の 3%オーストラリア: 引用元論文 323 件、この内訳の 2.9%カナダ: 引用元論文 323 件、この内訳の 2.8%スイス: 引用元論文 301 件、この内訳の 2.7%日本: 引用元論文 257 件、この内訳の 2.3%
0%24.4%その他 23.6%

機関

分野

  • Medicine77%
  • Biochemistry, Genetics and Molecular Biology11.4%
  • Immunology and Microbiology7%
  • Neuroscience1.5%
  • Computer Science0.8%
  • Chemistry0.4%
  • その他1.9%

トピック

  • Chronic Myeloid Leukemia Treatments11.9%
  • Chronic Lymphocytic Leukemia Research6.9%
  • Acute Myeloid Leukemia Research5.5%
  • Eosinophilic Disorders and Syndromes4.8%
  • Multiple Myeloma Research and Treatments3.7%
  • Acute Lymphoblastic Leukemia research3.6%
  • その他63.6%

共著者

全論文

検索で開く
  1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    著者: Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann - Leukemia 2020 被引用: 1,510

  2. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

    著者: Andreas Hochhaus, Richard A. Larson, François Guilhot, Jerald P. Radich, Susan Branford, Timothy P. Hughes, Michele Baccarani, Michael W. Deininger, Francisco Cervantes, Satoko Fujihara, Christine-Elke Ortmann, Hans D. Menssen, Hagop Kantarjian, Stephen G. O’Brien, Brian Druker - New England Journal of Medicine 2017 被引用: 1,259

  3. A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    著者: Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Siu‐Fun Wong, Stephanie Lustgarten, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, John M. Goldman, Neil P. Shah, Hagop M. Kantarjian - New England Journal of Medicine 2013 被引用: 1,124

  4. Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

    著者: Jörge E. Cortes, Dong‐Wook Kim, Javier Pinilla‐Ibarz, Philipp D. le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Stephanie Lustgarten, Victor M. Rivera, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, Neil P. Shah, Hagop M. Kantarjian - Blood 2018 被引用: 583

  5. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

    著者: Jörge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian, Michele Baccarani, Jiřı́ Mayer, Concepción Boqué, Neil P. Shah, Charles Chuah, Luís Casanova, Brigid Bradley-Garelik, George Manos, Andreas Hochhaus - Journal of Clinical Oncology 2016 被引用: 946

  6. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

    著者: Brian Druker, François Guilhot, Stephen G. O’Brien, Insa Gathmann, Hagop M. Kantarjian, Norbert Gattermann, Michael W. Deininger, Richard T. Silver, John M. Goldman, Richard M. Stone, Francisco Cervantes, Andreas Hochhaus, Bayard L. Powell, Janice Gabrilove, Philippe Rousselot, Josy Reiffers, Jan J. Cornelissen, Timothy P. Hughes, Hermine Agis, Thomas Fischer, Gregor Verhoef, John D. Shepherd, Giuseppe Saglio, Aloïs Gratwohl, Johan Lanng Nielsen, Jerald P. Radich, Bengt Simonsson, Kerry Taylor, Michele Baccarani, Charlene So, Laurie Letvak, Richard A. Larson - New England Journal of Medicine 2006 被引用: 3,481

  7. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

    著者: Stephen G. O’Brien, François Guilhot, Richard A. Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J. Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy P. Hughes, Klaus Lechner, Johan Lanng Nielsen, Philippe Rousselot, Josy Reiffers, Giuseppe Saglio, John D. Shepherd, Bengt Simonsson, Aloïs Gratwohl, John M. Goldman, Hagop M. Kantarjian, Kerry Taylor, Gregor Verhoef, Ann E. Bolton, Renaud Capdeville, Brian Druker - New England Journal of Medicine 2003 被引用: 3,565

  8. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

    著者: Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus, Jörge E. Cortes, Sandip Shah, Manuel Ayala, Beatriz Moiraghi, Zhixiang Shen, Jiřı́ Mayer, Ricardo Pasqüini, Hirohisa Nakamae, Françoise Huguet, Concepción Boqué, Charles Chuah, Eric Bleickardt, M. Brigid Bradley‐Garelik, Chao Zhu, Ted P. Szatrowski, Д. А. Шапиро, Michele Baccarani - New England Journal of Medicine 2010 被引用: 1,582

  9. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    著者: Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong‐Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman, Rüdiger Hehlmann - Blood 2013 被引用: 1,989

  10. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    著者: Robin Foà, Antonella Vitale, Marco Vignetti, Giovanna Meloni, Anna Guarini, Maria Stefania De Propris, Loredana Elia, Francesca Paoloni, Paola Fazi, Giuseppe Cimino, Francesco Nobile, Felicetto Ferrara, Carlo Castagnola, Simona Sica, Pietro Leoni, Eliana Zuffa, Claudio Fozza, Mario Luppi, Anna Candoni, Ilaria Iacobucci, Simona Soverini, Franco Mandelli, Giovanni Martinelli, Michele Baccarani, on behalf of the GIMEMA Acute Leukemia Working Party - Blood 2011 被引用: 461

  11. Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

    著者: Antonio Curti, Loredana Ruggeri, Alessandra D’Addio, Andrea Bontadini, Elisa Dan, Maria Rosa Motta, Sara Trabanelli, Valeria Giudice, Elena Urbani, Giovanni Martinelli, Stefania Paolini, Fiorenza Fruet, Alessandro Isidori, Sarah Parisi, Giuseppe Bandini, Michele Baccarani, Andrea Velardi, Roberto M. Lemoli - Blood 2011 被引用: 402

  12. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

    著者: Markus Pfirrmann, Michele Baccarani, Susanne Saußele, Joëlle Guilhot, Francisco Cervantes, G.J. Ossenkoppele, Verena Hoffmann, Fausto Castagnetti, Joerg Hasford, Rüdiger Hehlmann, Bengt Simonsson - Leukemia 2015 被引用: 300

  13. Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial

    著者: Jeffrey H. Lipton, Charles Chuah, Agnès Guerci‐Bresler, Gianantonio Rosti, David Simpson, Sarit Assouline, Gabriel Étienne, Franck E. Nicolini, Philipp le Coutre, Richard E Clark, Leif Stenke, David Andorsky, Vivian G. Oehler, Stephanie Lustgarten, Victor M. Rivera, Timothy Piers Clackson, Frank G. Haluska, Michele Baccarani, Jörge E. Cortes, François Guilhot, Andreas Hochhaus, Timothy P. Hughes, Hagop M. Kantarjian, Neil P. Shah, Moshe Talpaz, Michael Deininger - The Lancet Oncology 2016 被引用: 259

  14. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

    著者: Hagop M. Kantarjian, Neil P. Shah, Jörge E. Cortes, Michele Baccarani, M B Agarwal, María Soledad Undurraga, Jianxiang Wang, Juan Julio Kassack Ipiña, Dong‐Wook Kim, Michinori Ogura, Carolina Pavlovsky, Christian Junghanß, Jorge Milone, Franck E. Nicolini, Tadeusz Robak, Jan Van Droogenbroeck, Edo Vellenga, M. Brigid Bradley‐Garelik, Chao Zhu, Andreas Hochhaus - Blood 2011 被引用: 605

  15. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation

    著者: Elena Zamagni, Francesca Patriarca, Cristina Nanni, Beatrice Anna Zannetti, Emanuela Englaro, Annalisa Pezzi, Paola Tacchetti, Silvia Buttignol, Giulia Perrone, Annamaria Brioli, Lucia Pantani, Carolina Terragna, Francesca Carobolante, Michele Baccarani, Renato Fanin, Stefano Fanti, Michèle Cavo - Blood 2011 被引用: 533

  16. European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

    著者: Juan Luis Steegmann, Michele Baccarani, Massimo Breccia, Luis Felipe Casado, Valentín García‐Gutiérrez, Andreas Hochhaus, D.-W. Kim, T D Kim, H. Jean Khoury, P. Le Coutre, Jiří Mayer, Dragana Milojković, Kimmo Porkka, Delphine Réa, Gianantonio Rosti, Susanne Saußele, R. Hehlmann, Richard E. Clark - Leukemia 2016 被引用: 475

  17. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells

    著者: Antonio Curti, Simona Pandolfi, Barbara Valzasina, Michela Aluigi, Alessandro Isidori, Elisa Ferri, Valentina Salvestrini, Giuseppina Bonanno, Sergio Rutella, Ilaria Durelli, Alberto L. Horenstein, Francesca Fiore, Massimo Massaia, Mario P. Colombo, Michele Baccarani, Roberto M. Lemoli - Blood 2006 被引用: 388

  18. BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

    著者: Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi, Nadeem A. Vellore, Johanna Estrada, Franck E. Nicolini, H. Jean Khoury, Richard A. Larson, Marina Konopleva, Jörge E. Cortes, Hagop M. Kantarjian, Elias Jabbour, Steven M. Kornblau, Jeffrey H. Lipton, Delphine Réa, Leif Stenke, Gisela Barbany, Thoralf Lange, Juan Carlos Hernández‐Boluda, Gert J. Ossenkoppele, Richard D. Press, Charles Chuah, Stuart L. Goldberg, Meir Wetzler, François-Xavier Mahon, Gabriel Étienne, Michele Baccarani, Simona Soverini, Gianantonio Rosti, Philippe Rousselot, Ran Friedman, Marie Deininger, Kimberly R. Reynolds, William L. Heaton, Anna M. Eiring, Anthony D. Pomicter, Jamshid S. Khorashad, Todd W. Kelley, Riccardo Baron, Brian Druker, Michael W. Deininger, Thomas O’Hare - Cancer Cell 2014 被引用: 366

  19. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6

    著者: Marina Ratta, Francesco Fagnoni, Antonio Curti, Rosanna Vescovini, Paolo Sansoni, Barbara Oliviero, Miriam Fogli, Elisa Ferri, G. Robustelli della Cuna, S Tura, Michele Baccarani, Roberto M. Lemoli - Blood 2002 被引用: 447

  20. IKZF1 (Ikaros) Deletions in BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

    著者: Giovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, Marco Vignetti, Francesca Paoloni, Daniela Cilloni, Simona Soverini, Antonella Vitale, Sabina Chiaretti, Giuseppe Cimino, Cristina Papayannidis, Stefania Paolini, Loredana Elia, Paola Fazi, Giovanna Meloni, Sergio Amadori, Giuseppe Saglio, Fabrizio Pane, Michele Baccarani, Robin Foà - Journal of Clinical Oncology 2009 被引用: 322

  21. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview

    著者: for the International BCR-ABL Study Group, Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Gianantonio Rosti, Simona Soverini, Ali Albeer, Markus Pfirrmann - Leukemia 2019 被引用: 138

  22. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    著者: Mark J. Levis, Farhad Ravandi, Eunice S. Wang, Maria R. Baer, Alexander E. Perl, Steven Coutré, Harry P. Erba, Robert K. Stuart, Michele Baccarani, Larry D. Cripe, Martin S. Tallman, Giovanna Meloni, Lucy A. Godley, Amelia Langston, Sergio Amadori, Ian D. Lewis, Arnon Nagler, Richard M. Stone, Karen Yee, Anjali S. Advani, Dan Douer, W Wiktor-Jędrzejczak, Gunnar Juliusson, Mark R. Litzow, Stephen H. Petersdorf, Miguel Á. Sanz, Hagop M. Kantarjian, Takashi Sato, Lothar Tremmel, Debra M. Bensen-Kennedy, Donald Small, B. Douglas Smith - Blood 2011 被引用: 399

  23. Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

    著者: H. Jean Khoury, Jörge E. Cortes, Hagop M. Kantarjian, Carlo Gambacorti‐Passerini, Michele Baccarani, Dong‐Wook Kim, Andrey Zaritskey, Athena Countouriotis, Nadine Besson, Eric Leip, Virginia Kelly, Tim H. Brümmendorf - Blood 2012 被引用: 318

  24. Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

    著者: Fabio Efficace, Michele Baccarani, Massimo Breccia, Giuliana Alimena, Gianantonio Rosti, Francesco Cottone, Giorgio La Nasa, Claudia Baratè, Antonella Russo Rossi, Giuseppe Fioritoni, Luigia Luciano, Diamante Turri, Bruno Martino, Francesco Di Raimondo, Melissa Dabusti, Micaela Bergamaschi, Pietro Leoni, Maria Pina Simula, Luciano Levato, Stefano Ulisciani, Dino Veneri, Simona Sica, Alessandro Rambaldi, Marco Vignetti, Franco Mandelli, for GIMEMA - Blood 2011 被引用: 256